|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Immunomedics, Inc. (IMMU) to Participate in Brean Capital 2012 Life Sciences Summit
11/1/2012 6:58:39 AM
MORRIS PLAINS, N.J., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will participate in the Brean Capital 2012 Life Sciences Summit on Wednesday, November 7, 2012 at the Sentry Centers in New York City. This conference will feature small group sessions and one-on-one meetings with institutional clients. There will be no formal presentation.
|
|
|
|
|
|
|
|
|
|
|